HCP Personal Marketing Lead - Epilepsy

The role

You will own the strategy, development, execution, and optimization of HCP personal promotion and speaker programming initiatives. This role involves translating brand strategy and clinical evidence into promotional tools to engage healthcare professionals in a rare indication.

What you will do

• Lead HCP personal promotion strategy
• Develop and optimize field promotional materials
• Lead HCP speaker programming including planning, identification, onboarding, and training
• Partner with Sales and Sales Training to support launch readiness and field execution
• Translate clinical and scientific information into customer-relevant messaging
• Lead agency and vendor partners
• Evaluate promotional effectiveness using customer insights and performance data

Required qualifications

• Bachelor's degree
• Progressive experience in pharmaceutical or biotechnology HCP marketing, including personal promotion, field promotional materials, and/or HCP speaker programming
• Strong understanding of pharmaceutical promotional practices, field-based HCP engagement, and relevant regulatory and compliance requirements
• Demonstrated ability to influence cross-functional partners, manage agencies and vendors, and deliver high-quality work
• Regular use of a computer, devices or other office equipment
• Clear communication
• Occasional movement

Nice to have

• Advanced degree in business, life sciences, marketing, or a related field
• Pre-launch or launch experience
• Experience in rare disease, specialty pharmaceuticals, or marketing to focused HCP audiences

Benefits

• 99% of the premium paid for medical, dental and vision plans
• Company-paid life insurance
• AD&D
• Disability benefits
• Voluntary plans to personalize coverage
• Dollar-for-dollar 401(k) match up to 6%
• Long-term stock incentives
• ESPP
• Discretionary quarterly bonus
• Flexible wellness benefit
• Generous PTO
• Paid holidays and company-wide shutdowns

About the company

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders. The company focuses on developing high impact medicines for patients and families affected by complex brain disorders.